NasdaqGS:CBLLMedical Equipment
CeriBell (CBLL) Stock Premium Rides High Margins Despite Deeper Losses
CeriBell stock rose 10.4% to US$21.31 after its Q2 print, as traders focused on headline growth in this high margin medical device story. Revenue reached US$28.1m and the company reported a net loss of US$19.3m, which keeps profitability in the future for now.
The key point for long term investors is the tension between that loss-making profile and the rich price to sales multiple, recently around 8x compared with peers closer to 6.8x. The rest of the earnings report outlines why the market...